Healthcare Services

Lung Cancer Screening Industry Expansion Forecast Showing Market Size of $5.24 Billion by 2030 at 9.5% CAGR

April 2, 2026April 15, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Is The Market Size Of The Lung Cancer Screening Market Expected To Change Between 2026 And 2030?

The lung cancer screening market has experienced significant growth in recent years. It is anticipated to increase from $3.33 billion in 2025 to $3.65 billion in 2026, at a compound annual growth rate (CAGR) of 9.6%. The expansion observed in the past can be attributed to several factors, including the increasing occurrence of lung cancer among aging populations, greater awareness of the benefits of early screening, the development of diagnostic imaging infrastructure, improvements in CT imaging technology, and the implementation of guideline-based screening protocols.

The lung cancer screening market size is anticipated to demonstrate robust expansion in the forthcoming years. It is projected to climb to $5.24 billion by 2030, achieving a compound annual growth rate (CAGR) of 9.5%. The expansion during the forecast period is driven by factors such as the increasing implementation of AI-assisted diagnostic workflows, the broadening scope of population-based screening programs, a heightened concentration on personalized risk assessment, rising investments in technologies for early cancer detection, and increased healthcare policy backing for screening. Key trends during this period involve the rising adoption of low-dose CT screening programs, a growing integration of AI in imaging analysis, an enhanced focus on screening high-risk populations, the expansion of preventive oncology initiatives, and a greater emphasis on the early detection of lung cancer.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27331&type=smp

What Drivers Are Expected To Influence The Lung Cancer Screening Market During The Forecast Period?

The increasing prevalence of smoking is projected to boost the expansion of the lung cancer screening market in the coming period. Smoking involves inhaling smoke from burning materials, primarily tobacco, into the mouth and lungs. Elevated stress levels are contributing to the uptick in smoking rates, as individuals increasingly resort to it as a coping mechanism. Lung cancer screening aids in tackling growing smoking rates by allowing for the early identification of health risks linked to smoking, thereby encouraging people to cease the habit and bolstering wider public health initiatives to decrease tobacco consumption. For instance, in October 2024, the Office for Health Improvement & Disparities, a UK-based government organisation, reported that the prevalence of current smokers in the routine and manual occupation group (aged 18 to 64) in 2023 was 19.5%. Consequently, the escalation in smoking rates is propelling the growth of the lung cancer screening market.

How Is The Lung Cancer Screening Market Structured Across Different Segments?

The lung cancer screening market covered in this report is segmented –

1) By Diagnosis Type: Low Dose Spiral Computed Tomography Scan, Chest-X-Ray

2) By Cancer Type: Non-Small Cell Lung Cancer, Small Cell Lung Cancer

3) By Age Group: 50 And Older, Below 50

4) By End-User: Hospitals And Clinics, Diagnostic Centers, Other End-Users

Subsegments:

1) By Low Dose Spiral Computed Tomography Scan: Screening, Diagnostic, Follow-Up

2) By Chest X-Ray: Posterior Anterior, Lateral, Portable

What Major Market Trends Are Driving Changes In The Lung Cancer Screening Market?

Major companies operating in the lung cancer screening market are concentrating on developing advanced solutions, such as normal flagging, to improve diagnostic accuracy, reduce false positive results, and enhance the early identification of cancerous nodules. Normal flagging denotes a technological capability in lung cancer screening that automatically identifies and flags scans showing no abnormal findings, thus aiding in the prioritization of cases needing further evaluation. For example, in May 2025, Lunit Inc., a medical technology firm based in South Korea, introduced INSIGHT CXR4, its next-generation artificial intelligence (AI)-powered chest X-ray analysis solution, which has now achieved CE MDR-certification for deployment across Europe. This solution is engineered to assist radiologists by boosting diagnostic accuracy and workflow efficiency, detecting 12 chest abnormalities, including lung nodules, pneumonia, and acute bone fractures, and offering features like current-prior image comparison to support early disease detection and clinical decision-making.

Which Major Players Dominate The Lung Cancer Screening Market?

Major companies operating in the lung cancer screening market are Abbott Laboratories Inc., Canon Inc., Siemens Healthineers AG, Koninklijke Philips N.V., GE Healthcare Technologies Inc., Quest Diagnostics Incorporated, Shimadzu Corporation, NeoGenomics Laboratories Inc., Freenome Holdings Inc., Biodesix Inc., Lunit Inc., Infervision, Riverain Technologies, VisionGate, Delfi Diagnostics Inc., Hologic Inc., Fujifilm Holdings Corporation, United Imaging Healthcare Co. Ltd., Samsung Medison Co. Ltd., Carestream Health Inc., Analogic Corporation, Toshiba Medical Systems Corporation

Read the full lung cancer screening market report here:

https://www.thebusinessresearchcompany.com/report/lung-cancer-screening-global-market-report

Which Region Is Forecast To Lead The Lung Cancer Screening Market In Terms Of Market Size?

North America was the largest region in the lung cancer screening market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lung cancer screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Lung Cancer Screening Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27331&type=smp

Browse Through More Reports Similar to the Global Lung Cancer Screening Market 2026, By The Business Research Company

Financial Fraud Detection Software Global Market Report

https://www.thebusinessresearchcompany.com/report/financial-fraud-detection-software-global-market-report

Payment Monitoring Global Market Report

https://www.thebusinessresearchcompany.com/report/payment-monitoring-global-market-report

Ecommerce Fraud Detection And Prevention Global Market Report

https://www.thebusinessresearchcompany.com/report/ecommerce-fraud-detection-and-prevention-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795